FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) Trading Down 3.5% – What’s Next?

FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT)’s stock price was down 3.5% during mid-day trading on Tuesday . The company traded as low as $39.40 and last traded at $38.37. Approximately 11,776 shares were traded during trading, The stock had previously closed at $39.75.

FT Vest U.S. Equity Deep Buffer ETF – October Trading Down 4.2 %

The business has a fifty day simple moving average of $39.65 and a two-hundred day simple moving average of $39.39. The company has a market cap of $273.34 million, a PE ratio of 26.64 and a beta of 0.35.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DOCT. Sunbelt Securities Inc. lifted its holdings in FT Vest U.S. Equity Deep Buffer ETF – October by 129.7% in the 3rd quarter. Sunbelt Securities Inc. now owns 3,515 shares of the company’s stock valued at $137,000 after purchasing an additional 1,985 shares in the last quarter. Arkadios Wealth Advisors acquired a new stake in shares of FT Vest U.S. Equity Deep Buffer ETF – October in the 4th quarter worth $214,000. AlphaMark Advisors LLC increased its stake in shares of FT Vest U.S. Equity Deep Buffer ETF – October by 223.4% in the 4th quarter. AlphaMark Advisors LLC now owns 1,520 shares of the company’s stock worth $60,000 after acquiring an additional 1,050 shares during the last quarter. Finally, Creative Financial Designs Inc. ADV increased its stake in shares of FT Vest U.S. Equity Deep Buffer ETF – October by 40.6% in the 4th quarter. Creative Financial Designs Inc. ADV now owns 1,326 shares of the company’s stock worth $52,000 after acquiring an additional 383 shares during the last quarter.

About FT Vest U.S. Equity Deep Buffer ETF – October

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.